Loading...
Current guidelines recommend annual anal cancer screening for HIV-infected women with a history of abnormal cervical cytology or receptive anal intercourse (RAI). However, anal high-grade squamous intraepithelial lesions (HSIL) have been observed in HIV-infected women with or without those risk factors.
To determine whether current guidelines adequately identify HIV-infected women at risk for anal HSIL, investigators conducted a retrospective cohort study at a medical center where, since 2009, all HIV-infected persons were offered annual anal cytology screening, regardless of cancer risk factors. Patients with abnormal cytology were then referred for high-resolution anoscopy (HRA) with biopsy of suspicious areas.
Of 745 women who underwent sc…